(M2 PressWIRE Via Acquire Media NewsEdge) WEALTHMAKERS.COM / www.wealthmakers.com , a Wall Street research and trading firm providing unbiased statistical stock market predictions to empower investors, securities professionals and public company employees to make precise, predictive and profitable trading decisions, has issued new research reports today on the following stocks: Clough Global Opportunities Fund (AMEX:GLO), Gentiva Health Services Inc (NASDAQ:GTIV), IMAX CORP (NYSE:IMAX), Jinkosolar Holding Co Ltd (NYSE:JKS), Keryx Biopharmaceuticals Inc (NASDAQ:KERX), Quicksilver Resources Inc (NYSE:KWK)
Click here to download each report:
Clough Global Opportunities Fund (AMEX:GLO): http://www.wealthmakers.com/ireport/22582
Gentiva Health Services Inc (NASDAQ:GTIV): http://www.wealthmakers.com/ireport/22611
IMAX CORP (NYSE:IMAX): http://www.wealthmakers.com/ireport/22600
Jinkosolar Holding Co Ltd (NYSE:JKS): http://www.wealthmakers.com/ireport/22613
Keryx Biopharmaceuticals Inc (NASDAQ:KERX): http://www.wealthmakers.com/ireport/22395
Quicksilver Resources Inc (NYSE:KWK): http://www.wealthmakers.com/ireport/22590
WealthMakers is powered by WOPR (WealthMakers Online Predictive Research), www.wopronline.com , a network of statistical servers with unbridled computing power to analyze exactly what event ( technicals, fundamentals, earnings, seasonality, short squeeze, group rotation, chart patterns, insider buying/selling and multiple other factors) will move each stock, in which direction, to what % degree, in the specific amount of time and with what degree of probability. Based on IBMs work on Deep Blue (now called "Watson"), this powerful database technology matched with hundreds of data feeds and the ability to find patterns, that humans cannot, has the ability to do the work of hundreds or thousands of analysts without getting tired (24 hours per day / 7 days per week). Our unparalleled technology, trading algorithms and proprietary data generate confident predictions, with clear and concise objectives resulting in unique and innovative research reports that move markets and create exponential returns to our clients.
Click here to LIKE us on Facebook:
Click here to FOLLOW us on Twitter:
Click here to access WealthMakers technology:
Users access these powerful research reports though the PowerTrader Matrix. The Matrix automatically scans through 14,000 stocks, 11 strategies and real-time price updates to find only those stocks that have multiple predictions, at the same time, in the same direction, with no conflicting predictions and the fundamental value of the stock is in-line with the direction of the trade. This powerful technology filters out the exact long/short trades that our trading network need to enter at the precise time and price that they should be entered and exited.
To learn more click here: http://www.buyins.com/woprbrochure.pdf
WealthMakers Power Trader works because the Market Read strategies have a very high success rate. "accuracy", "average return" and "average # of days in trade" are tracked in real-time and documented at www.buyins.com/images/stats.pdf
Clough Global Opportunities Fund (AMEX:GLO) - CLOUGH OPPORTUNITIES
Gentiva Health Services Inc (NASDAQ:GTIV) - Gentiva Health Services, Inc. provides home health services and hospice services in the United States. It offers skilled nursing and therapy services and paraprofessional nursing services to adult and elder patients through licensed and Medicare-certified agencies. The company also provides its services through specialty programs comprising Gentiva Orthopedics, which offers individualized home orthopedic rehabilitation services to patients recovering from joint replacement or other major orthopedic surgery; Gentiva Safe Strides that provides therapies for patients with balance issues; and Gentiva Cardiopulmonary, which helps patients and their physicians manage heart and lung health in a home-based environment. In addition, its specialty programs include Gentiva Neurorehabilitation, which helps patients who have experienced a neurological injury or condition by removing the obstacles to healing in the patient s home; and Gentiva Senior Health that addresses the needs of patients with age-related diseases and issues. Further, the company offers consulting services, such as operational support, billing and collection activities, and on-site agency support to home health agencies. Additionally, it provides hospice services through Dementia Specialty Program that offers an individualized disease management program addressing the physical needs of Alzheimer s and dementia patients; Cancer Specialty Program, which provides pain and symptom management for patients with cancer; Cardiac Specialty Program that helps patients and their physicians manage symptoms associated with heart disease; and Pulmonary Specialty Program, which addresses the needs of patients who have experienced a respiratory crisis. The company offers its hospice services primarily in the patient s home or other residence, such as an assisted living residence, nursing home, and in a hospital. Gentiva Health Services, Inc. was founded in 1999 and is headquartered in Atlanta, Georgia.
IMAX CORP (NYSE:IMAX) - IMAX Corporation, together with its subsidiaries, operates as an entertainment technology company specializing in motion picture technologies and presentations worldwide. The company operates in seven segments: IMAX Systems, Theater System Maintenance, Joint Revenue Sharing Arrangements, Film Production and IMAX Digital Re-Mastering (DRM), Film Distribution, Film Post-Production, and Other. The IMAX Systems segment designs, manufactures, sells, or leases IMAX theater projection system equipment. The Theater System Maintenance segment maintains IMAX theater projection system equipment in the IMAX theater network. The Joint Revenue Sharing Arrangements segment provides IMAX theater projection system equipment to an exhibitor in exchange for a share of the box-office and concession revenues. The Film Production and IMAX DMR segment produces films and performs film re-mastering services. The Film Distribution segment distributes films for which the company has distribution rights. The Film Post-Production segment offers film post-production and film print services. The Other segment owns and operates IMAX theaters; rents two-dimensional and three-dimensional (3D) large-format film and digital cameras to third party production companies; and offers after market sales services for projection system parts and 3D glasses. The company serves institutional customers, such as science and natural history museums, zoos, aquaria, and other educational and cultural centers, as well as commercial multiplex exhibitors. IMAX Corporation also sells or leases its theater systems to theme parks, tourist destination sites, fairs, and expositions. As of September 30, 2012, it operated 689 IMAX theatres, including 556 commercial multiplexes, 20 commercial destinations, and 113 institutional theaters in 52 countries. The company was founded in 1967 and is headquartered in Mississauga, Canada.
Jinkosolar Holding Co Ltd (NYSE:JKS) - JinkoSolar Holding Co., Ltd., together with its subsidiaries, engages in designing, developing, producing, and marketing photovoltaic products in the People s Republic of China and internationally. It offers solar modules; solar cells; mono and multi crystalline silicon ingots and silicon wafers; recovered silicon materials; solar power project development and solar system integration services; and processing services. The company sells its solar modules to distributors, project developers, system integrators, and other players in the solar power industry under the JinkoSolar brand, as well as on an original equipment manufacturer basis. JinkoSolar Holding Co., Ltd. has a strategic cooperation agreement with Jinchuan Group co.,ltd. to invest and develop a 200 MW photovoltaic solar power plant in Jinchang, Gansu Province. The company was founded in 2006 and is based in Shangrao, the People s Republic of China.
Keryx Biopharmaceuticals Inc (NASDAQ:KERX) - Keryx Biopharmaceuticals, Inc., a biopharmaceutical company, focuses on the acquisition, development, and commercialization of pharmaceutical products for the treatment of renal disease in the United States. It is developing Zerenex (ferric citrate), an oral, ferric iron-based compound that has the capacity to bind to phosphate in the gastrointestinal tract and form non-absorbable complexes. Zerenex is in Phase III clinical development for the treatment of hyperphosphatemia in patients with end-stage renal disease on dialysis. The company has sublicense agreement with Japan Tobacco Inc. and Torii Pharmaceutical Co., Ltd. for the development and commercialization of ferric citrate in Japan. Keryx Biopharmaceuticals, Inc. was founded in 1997 and is headquartered in New York, New York.
Quicksilver Resources Inc (NYSE:KWK) - Quicksilver Resources Inc., an independent oil and gas company, engages in the acquisition, exploration, development, and production of onshore oil and gas in North America. The company focuses primarily on unconventional reservoirs, such as fractured shales, coal beds, and tight sands. It owns producing oil and natural gas properties principally in Texas, Colorado, Wyoming, and Montana, as well as in Alberta and British Columbia. The company primarily holds interests in assets covering an area of approximately 140,000 net acres located in the Barnett Shale, Fort Worth basin, north Texas; exploratory licenses covering an area of approximately 130,000 net acres located in the Horn River basin of northeast British Columbia; and assets covering an area of approximately 36,929 net undeveloped acres located in the Horseshoe Canyon, southern and central Alberta. As of December 31, 2011, it had total proved reserves of approximately 2.8 trillion cubic feet of natural gas equivalents. The company was founded in 1997 and is headquartered in Fort Worth, Texas.
Wealthmakers Online Predictive Research (WOPR) is a distributed computing system that has hundreds of data feeds (economic, weather, geopolitical, interest rates, energy, equities, currencies, commodities, etc.) feeding into a relational database that searches for patterns and determines how a trading instrument has behaved both before and after specific events have taken place in the past. Only about 25% of stocks display patterns at any given time and only about 1% of stocks exhibit all the necessary conditions on any given day to make a trade. That means that out of 14,000 stocks, only about 140 trades are high probability trades that our system would generate a research report on and disseminate the information to clients. This process eliminates the noise and only tells you which stocks have multiple strategies lining up at the same time, in the same direction, with no conflicting predictions and the fundamental valuation is in-line with the prediction!
EARNINGS - Most stock price histories show random or unpredictable movements around earnings reports. But some repeat the same pattern quarter after quarter, year after year. Earnings predict probability, price move and length of move before and after all US stock earnings reports.
FRICTION FACTOR - Friction Factor is based on the relationship between the price of a stock and the volume at which it's bought and sold. Normal and abnormal Friction factor patterns can help you time your buying and selling decisions for maximum earnings potential.
GATS - The Global Automated Trading System (GATS) combines neural networks and genetic algorithms to reduce investment risks. GATS selects the highest probability trades in stocks, bonds, options, commodities, currencies and private equities, delivering precise, predictive and profitable data.
GROUP SECTOR - Certain institutions can exert buying or selling pressure over an entire industry group, pushing prices higher. Group Sector identifies stocks that most closely match their group's movement and generate powerful group consensus trading signals to help you profit from the herd mentality.
PATTERN SCANNER - describes the current technical situation in your stock. It displays the technicals, trend conditions and seasonal factors and automatically discovers how that stock has performed in the trading days following the occurrences of the event or combination of events. This technology automatically scans using complex historical queries based on what event is taking place right now in the stock. It then displays the probability, expected return and number of trading days for the expected move.
EVENTS - This technology automatically tracks "Trigger Events" that positively or negatively affect the value of a stock or its perceived value among analysts ranging from price fluctuations to natural disasters and political shifts. The results reveal patterns that can predict market movements.
RegSHO NAKED SHORTS - SEC Regulation SHO mandates that if a clearing agent holds a fail-to-deliver position for 13 consecutive settlement days, it must purchase securities to close out its position, a.k.a. a forced cover. WealthMakers aggregates data from NYSE, AMEX, NASDAQ, OTCBB and PINKSHEETS to track stocks that are about to have forced covers.
SEASONALITY - Seasonality analyzes more than 20 years of data to determine if stocks have a long or short seasonal bias, how many trading days the move is expected to last, the probability of that move and the percentage move the stock is expected to make based on the seasonal bias.
SQUEEZETRIGGER - Our proprietary database of more than 3,500,000,000 short sale transactions allows us to calculate the exact price at which the total short interest is short in each stock. Squeeze Trigger Alerts let you know exactly when a short squeeze will start and how to trade profitably.
VALUATION - A stock's value is a function of its forecasted earnings per share and forecasted earnings growth, as well as profitability, interest and inflation rates. Valuation use these metrics to determine at what price a stock is undervalued or overvalued, so that you can make investment decisions accordingly.
INSIDER - Significant stock sales or purchases by company "insiders" (officers or directors) can be a predictor of future price movements, up or down. The Insider strategy tracks these actions and correlates them with historical data to give you an investment edge.
WEALTHMAKERS is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell any securities. WEALTHMAKERS has not been compensated by any of the above mentioned companies specifically for this report. Past performance is not indicative of future results. Please visit our web site, www.wealthmakers.com , for complete risks and disclosures.
((M2 Communications disclaims all liability for information provided within M2 PressWIRE. Data supplied by named party/parties. Further information on M2 PressWIRE can be obtained at http://www.presswire.com on the world wide web. Inquiries to firstname.lastname@example.org)).